Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring
Oncoimmunology
.
2012 Dec 1;1(9):1457-1459.
doi: 10.4161/onci.22308.
Authors
Axel Hoos
1
,
Sylvia Janetzki
,
Cedrik M Britten
Affiliation
1
Glaxo Smith Kline, Collegeville, PA USA ; Cancer Immunotherapy Consortium; Cancer Research Institute; New York, NY USA.
PMID:
23264891
PMCID:
PMC3525600
DOI:
10.4161/onci.22308
No abstract available